Knowledge Center
Article / Aug 30, 2016
Accelerating approval and reducing costs of spray dried drugs through development by design
Source:
Pharma's Almanac, Global Pharmaceutical Supply Chain Trends, Q3 2016
Contract development and manufacturing organizations with unique technical capabilities and expertise are able to speed up the development and commercialization of novel medicines. Effective application of its extensive knowledge, data base and Development by Design approach has enabled Hovione to accelerate spray drying development, simultaneously reducing cost and time to get challenging drugs to patients in need.
Related links
Also in the Knowledge Center
/ Feb 24, 2021
Webinar - Computational Methods and High Throughput Screening in the Formulation of ASDs
Read more
Scientific Article
/ Feb 12, 2021
Webinar - From Lab to Commercial: Fully Integrated Solutions for Dry Powder Inhalation
Read more
Scientific Article
/ Feb 02, 2022
Webinar - Process safety evaluation and scale-up resorting to mechanistic modelling for exothermic and gas releasing reactions
Read more
Scientific Article